Galera Therapeutics, Inc.
GRTXDelisted Sep 6, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001563577
Galera Therapeutics, Inc. was delisted on Sep 6, 2024; its insiders filed their last Form 4 on Aug 5, 2026; 36 institutions reported holding it in 13F filings for Q1 2024, worth $1.37M in total; no superinvestor held it.
13F holders, Q1 2026
Institutional positions in Galera Therapeutics, Inc. as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
GRTX is no longer listed, and 13F filings after Q1 2024 list far fewer holders. See Q1 2024
- Institutional holders
- 1
- +1 vs. Q4 2025
- Shares held
- 93
- +93 vs. Q4 2025
- Total value
- $4
- +$4 vs. Q4 2025
- New holders
- 1
- 0 more added
- Sold out
- 0
- 0 more reduced
Compare with Q4 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting GRTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 1 | $4 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 1 | $7.13K |
| Q1 2024 | 36 | $1.37M |
| Q4 2023 | 37 | $1.88M |
| Q3 2023 | 38 | $1.53M |
| Q2 2023 | 55 | $57.8M |
| Q1 2023 | 40 | $47.8M |
| Q4 2022 | 32 | $17.9M |
| Q3 2022 | 33 | $18.1M |
| Q2 2022 | 39 | $13.7M |
| Q1 2022 | 47 | $26.9M |
| Q4 2021 | 44 | $50.6M |
| Q3 2021 | 40 | $161.8M |
| Q2 2021 | 47 | $201.5M |
| Q1 2021 | 54 | $168.5M |
Institutions, Q1 2026
Shares, value and share of portfolio for each institution holding Galera Therapeutics, Inc.; share changes are against Q4 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Golden State Equity Partners | 93 | $4 | 0.00% | +93 | New |